<DOC>
	<DOCNO>NCT00095056</DOCNO>
	<brief_summary>The purpose study determine safety tolerability investigational drug patient Type 2 Diabetes Mellitus ( specific type diabetes ) Chronic Renal Insufficiency ( inadequate kidney function ) .</brief_summary>
	<brief_title>An Investigational Drug Patients With Type 2 Diabetes Mellitus Chronic Renal Insufficiency ( 0431-028 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Glipizide</mesh_term>
	<criteria>Patients least 18 year age diagnose type 2 diabetes mellitus ( T2DM ) ( specific type diabetes ) . Patient renal ( kidney ) insufficiency ( inadequate kidney function ) Patient heart problem ( heart attack chest pain ) stroke within past 6 month condition therapy , opinion investigator , may patient 's best interest participate . Pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Type 2 Diabetes Mellitus Chronic Renal Insufficiency</keyword>
</DOC>